| Business Summary | | Novamed,
Inc.
is
a
medical
device
holding
company
that
develops,
manufactures
and
markets
hydrogel-
and
saline-filled
breast
implant
products.
The
Company
currently
derives
all
of
its
sales
revenue
from
the
sale
of
prosthesis
products
outside
of
North
America.
Novamed
manufactures
and
markets
two
different
pre-filled
single-lumen
mammary
prostheses
(breast
implants),
the
Novagold
and
the
Novasaline.
Both
products
are
used
for
routine
cosmetic
breast
augmentation
and
for
breast
reconstruction
following
either
subcutaneous
or
modified
radical
mastectomy.
The
Company's
flagship
product
is
the
Novagold
breast
implant,
which
utilizes
a
unique
water-based
filling
material
that
is
designed
to
be
biocompatible
and
therefore
safe
for
human
use.
This
product
has
been
approved
for
sale
in
Europe
under
the
CE
Mark
regulatory
process
since
February
1996.
The
Company
has
further
developed
an
inflatable
Novasaline
breast
implant
product. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Novamed,
Inc.,
is
a
medical
device
holding
company
that
develops,
manufactures
and
markets
hydrogel
and
saline
filled
breast
implant
products
that
are
used
in
augmentations,
revisions,
or
reconstructive
procedures.
For
the
three
months
ended
3/31/01,
revenues
totalled
$0
vs.
$371
thousand.
Net
loss
rose
22%
to
$349
thousand.
Revenues
reflect
the
suspension
of
sales
due
to
the
MDA
alert
notice.
Higher
loss
reflects
costs
of
eliminating
the
German
subsidiary. | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Ruairidh Campbell, 36 Pres,
CEO, Chief Financial Officer, Director | $120K | Dollar
amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|